Viewing Study NCT00584961


Ignite Creation Date: 2025-12-24 @ 12:14 PM
Ignite Modification Date: 2026-02-07 @ 6:39 AM
Study NCT ID: NCT00584961
Status: COMPLETED
Last Update Posted: 2021-02-21
First Post: 2007-12-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: BIMET Study: Evolution of Metabolic and Cardiovascular Risks Factors in Patients With Bipolar Disorder
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bipolar Disorder View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Metabolic Syndrome, Bipolar Disorder and Cardiovascular Risk Factors View